Reverse cholesterol transport pathway in experimental chronic renal failure.
about
Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failureMetabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseAtherosclerosis in chronic kidney disease: the role of macrophagesStatins in the management of dyslipidemia associated with chronic kidney disease.Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.HDL abnormalities in nephrotic syndrome and chronic kidney disease.HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.High-density lipoprotein particle pattern and overall lipid responses to a short-term moderate-intensity aerobic exercise training intervention in patients with chronic kidney disease.Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke.
P2860
Q28566456-FFD58C0E-86E2-4444-B9A7-773244931FC8Q34336370-B3ED06F1-0FC8-4A20-94E3-E62F57DE502FQ35747579-56711C77-0022-4F88-9925-D32982F5559DQ35760064-6B2DB360-5301-4FCB-893B-7EC93AA8456BQ36721867-21906D6B-75DF-4C7B-BCE0-4BE4D9987E54Q36788430-73B28024-077D-49CB-AC96-8B7E26999E4FQ37811885-30FBEA09-71F4-44A1-BFC9-5BE07E74A505Q37986355-90A2F628-04B1-4134-BB04-162D568EA811Q38076217-7EE11BF1-9CD3-4961-B631-98A42E869836Q38131300-B36181CB-F473-40D4-969A-3438B2FB6D83Q38633497-ADCCE5AD-965E-450E-B3ED-FE5ED26D312CQ40587729-3A33A71D-0F69-437A-965D-8B4DDBC57AABQ41511008-2633B549-B78C-4BEF-9DC7-3A6228485292Q43247391-F887AEB2-0661-49EA-BEE2-33209F273505Q44698833-C8B1A735-37B2-44E4-8488-2F2884276DAD
P2860
Reverse cholesterol transport pathway in experimental chronic renal failure.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Reverse cholesterol transport pathway in experimental chronic renal failure.
@ast
Reverse cholesterol transport pathway in experimental chronic renal failure.
@en
type
label
Reverse cholesterol transport pathway in experimental chronic renal failure.
@ast
Reverse cholesterol transport pathway in experimental chronic renal failure.
@en
prefLabel
Reverse cholesterol transport pathway in experimental chronic renal failure.
@ast
Reverse cholesterol transport pathway in experimental chronic renal failure.
@en
P2093
P2860
P356
P1476
Reverse cholesterol transport pathway in experimental chronic renal failure.
@en
P2093
Hamid Moradi
Keith Norris
Nosratola D Vaziri
P2860
P304
P356
10.1159/000210020
P577
2009-03-24T00:00:00Z